Molecular genetics of Müllerian duct formation, regression and differentiation

Sexual Development

Volumn 8, Issue 5, 2014, Pages 281-296

  Mullen, Rachel D ^a   Behringer, Richard R ^a,b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Anti M llerian hormone; Human reproductive tract disorders; M llerian duct; Regression; Reproductive tract organogenesis; Sex differentiation; Signal transduction

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; EMBRYOLOGY; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MUELLERIAN DUCT;

ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENITALIA, FEMALE; HUMANS; MALE; MULLERIAN DUCTS;

EID: 84924910016     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000364935     Document Type: Article

References (117)

1. Allard S, Adin P, Gouedard L, di Clemente N, Josso N, et al: Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin. Development 127: 3349-3360 (2000)
2. Arango NA, Lovell-Badge R, Behringer RR: Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99: 409-419 (1999)
3. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J: Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288: 276-283 (2005)
4. Arango NA, Kobayashi A, Wang Y, Jamin SP, Lee HH, et al: A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol Reprod Dev 75: 1154-1162 (2008)
5. Austin HB: DiI analysis of cell migration during Mullerian duct regression. Dev Biol 169: 29-36 (1995)
6. Barakat AY, Papadopoulou ZL, Chandra RS, Hollerman CE, Calcagno PL: Pseudohermaphroditism, nephron disorder and Wilms' tumor: a unifying concept. Pediatrics 54: 366-369 (1974)
7. Barbacci E, Reber M, Ott MO, Breillat C, Huetz F, Cereghini S: Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development 126: 4795-4805 (1999)
8. Behringer RR: The in vivo roles of Mullerian-inhibiting substance. Curr Top Dev Biol 29: 171-187 (1994)
9. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL: Abnormal sexual development in transgenic mice chronically expressing Mullerian inhibiting substance. Nature 345: 167-170 (1990)
10. Behringer RR, Finegold MJ, Cate RL: Mullerianinhibiting substance function during mammalian sexual development. Cell 79: 415-425 (1994)
11. Belville C, Josso N, Picard JY: Persistence of Mullerian derivatives in males. Am J Med Genet 89: 218-223 (1999)
12. Belville C, Marechal JD, Pennetier S, Carmillo P, Masgrau L, et al: Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet 18: 3002-3013 (2009)
13. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL: Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122: 2687-2696 (1996)
14. Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ: A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351: 792-798 (2004)
15. Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ: WNT4 deficiency-a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod 22: 224-229 (2007)
16. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, et al: Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int 61: 1243-1251 (2002)
17. Block K, Kardana A, Igarashi P, Taylor HS: In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 14: 1101-1108. (2000)
18. Bouchard M, Souabni A, Mandler M, Neubuser A, Busslinger M: Nephric lineage specification by Pax2 and Pax8. Genes Dev 16: 2958-2970 (2002)
19. Brembeck FH, Rosario M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59 (2006)
20. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP: Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9: 283-292 (2005)
21. Cermik D, Selam B, Taylor HS: Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 238-243 (2003)
22. Cheng Z, Zhu Y, Su D, Wang J, Cheng L, et al: A novel mutation of HOXA10 in a Chinese woman with a Mullerian duct anomaly. Hum Reprod 26: 3197-3201 (2011)
23. Coffinier C, Barra J, Babinet C, Yaniv M: Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev 89: 211-213 (1999a)
24. Coffinier C, Thepot D, Babinet C, Yaniv M, Barra J: Essential role for the homeoprotein vHNF1/ HNF1beta in visceral endoderm differentiation. Development 126: 4785-4794 (1999b)
25. Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BR: Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 52: 6125-6128 (1992)
26. Cox S, Smith L, Bogani D, Cheeseman M, Siggers P, Greenfield A: Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Mullerian duct. Mol Reprod Dev 73: 1008-1016 (2006)
27. Davis RJ, Harding M, Moayedi Y, Mardon G: Mouse Dach1 and Dach2 are redundantly required for Mullerian duct development. Genesis 46: 205-213 (2008)
28. Denys P, Malvaux P, Van Den Berghe H, Tanghe W, Proesmans W: Association of an anatomopathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism (in French). Arch Fr Pediatr 24: 729-739 (1967).
29. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, et al: Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 18: 6653-6665 (1998)
30. Deutscher E, Hung-Chang Yao H: Essential roles of mesenchyme-derived beta-catenin in mouse Mullerian duct morphogenesis. Dev Biol 307: 227-236 (2007)
31. di Clemente N, Belville C: Anti-Mullerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 20: 599-610 (2006)
32. Dohr G, Tarmann T, Schiechl H: Different antigen expression on Wolffian and Mullerian cells in rat embryos as detected by monoclonal antibodies. Anat Embryol (Berl) 176: 239-242 (1987)
33. Dreyer C, Ellinger-Ziegelbauer H: Retinoic acid receptors and nuclear orphan receptors in the development of Xenopus laevis . Int J Dev Biol 40: 255-262 (1996)
34. Dyche WJ: A comparative study of the differentiation and involution of the Mullerian duct and Wolffian duct in the male and female fetal mouse. J Morphol 162: 175-209 (1979)
35. Ekici AB, Strissel PL, Oppelt PG, Renner SP, Brucker S, et al: HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina. Gene 518: 267-272 (2013)
36. Farikullah J, Ehtisham S, Nappo S, Patel L, Hennayake S: Persistent Mullerian duct syndrome: lessons learned from managing a series of eight patients over a 10-year period and review of literature regarding malignant risk from the Mullerian remnants. BJU Int 110:E1084-E1089 (2012)
37. Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF: Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 277: 33398-33410 (2002)
38. Folch M, Pigem I, Konje JC: Mullerian agenesis: etiology, diagnosis, and management. Obstet Gynecol Surv 55: 644-649 (2000)
39. Franco HL, Dai D, Lee KY, Rubel CA, Roop D, et al: WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J 25: 1176-1187 (2011)
40. Fujino A, Arango NA, Zhan Y, Manganaro TF, Li X, et al: Cell migration and activated PI3K/ AKT-directed elongation in the developing rat Mullerian duct. Dev Biol 325: 351-362 (2009)
41. Gao F, Maiti S, Sun G, Ordonez NG, Udtha M, et al: The Wt1 +/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome. Mol Cell Biol 24: 9899-9910 (2004)
42. Gendron RL, Paradis H, Hsieh-Li HM, Lee DW, Potter SS, Markoff E: Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol Reprod 56: 1097-1105 (1997)
43. Gervasini C, Grati FR, Lalatta F, Tabano S, Gentilin B, et al: SHOX duplications found in some cases with type I Mayer-Rokitansky-Kuster-Hauser syndrome. Genet Med 12: 634-640 (2010)
44. Goodman FR, Scambler PJ: Human HOX gene mutations. Clin Genet 59: 1-11 (2001)
45. Goodman FR, Bacchelli C, Brady AF, Brueton LA, Fryns JP, et al: Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 67: 197-202 (2000)
46. Gruenwald P: The relation of the growing Mullerian duct to the Wolffian duct and its importance for the genesis of malformations. Anat Rec 81: 1-19 (1941)
47. Guioli S, Sekido R, Lovell-Badge R: The origin of the Mullerian duct in chick and mouse. Dev Biol 302: 389-398 (2007)
48. Hossain A, Saunders GF: Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter. Biol Reprod 69: 1808-1814 (2003)
49. Hurst CH, Abbott B, Schmid JE, Birnbaum LS: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) disrupts early morphogenetic events that form the lower reproductive tract in female rat fetuses. Toxicol Sci 65: 87-98 (2002)
50. Hutson JM, Fallat ME, Kamagata S, Donahoe PK, Budzik GP: Phosphorylation events during Mullerian duct regression. Science 223: 586-589 (1984)
51. Iizuka-Kogo A, Ishidao T, Akiyama T, Senda T: Abnormal development of urogenital organs in Dlgh1-deficient mice. Development 134: 1799-1807 (2007)
52. Imhoff FM, Yang D, Mathew SF, Clarkson AN, Kawagishi Y, et al: The type 2 anti-Mullerian hormone receptor has splice variants that are dominant-negative inhibitors. FEBS Lett 587: 1749-1753 (2013)
53. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S: Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272: 22389-22392 (1997)
54. Jacob M, Konrad K, Jacob HJ: Early development of the Mullerian duct in avian embryos with reference to the human. An ultrastructural and immunohistochemical study. Cells Tissues Organs 164: 63-81 (1999)
55. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR: Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32: 408-410 (2002)
56. Jeong JW, Lee HS, Franco HL, Broaddus RR, Taketo MM, et al: Beta-catenin mediates glandular formation and dysregulation of betacatenin induces hyperplasia formation in the murine uterus. Oncogene 28: 31-40 (2009)
57. Josso N, Picard JY, Trah D: The antimullerian hormone. Recent Prog Horm Res 33: 117-167 (1976)
58. Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, et al: Anti-mullerian hormone: the Jost factor. Recent Prog Horm Res 48: 1-59 (1993)
59. Kastner P, Mark M, Ghyselinck N, Krezel W, Dupe V, et al: Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124: 313-326 (1997)
60. Kawakami Y, Wada N, Nishimatsu S, Nohno T: Involvement of frizzled-10 in Wnt-7a signaling during chick limb development. Dev Growth Differ 42: 561-569 (2000)
61. Klattig J, Sierig R, Kruspe D, Besenbeck B, Englert C: Wilms' tumor protein Wt1 is an activator of the anti-Mullerian hormone receptor gene Amhr2 . Mol Cell Biol 27: 4355-4364 (2007)
62. Kobayashi A, Behringer RR: Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4: 969-980 (2003)
63. Kobayashi A, Shawlot W, Kania A, Behringer RR: Requirement of Lim1 for female reproductive tract development. Development 131: 539-549 (2004)
64. Kobayashi A, Stewart CA, Wang Y, Fujioka K, Thomas NC, et al: β-Catenin is essential for Mullerian duct regression during male sexual differentiation. Development 138: 1967-1975 (2011)
65. Kolatsi-Joannou M, Bingham C, Ellard S, Bulman MP, Allen LI, et al: Hepatocyte nuclear factor-1β: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol 12: 2175-2180 (2001)
66. Lapointe E, Boyer A, Rico C, Paquet M, Franco HL, et al: FZD1 regulates cumulus expansion genes and is required for normal female fertility in mice. Biol Reprod 87: 104 (2012)
67. Ledig S, Schippert C, Strick R, Beckmann MW, Oppelt PG, Wieacker P: Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil Steril 95: 1589-1594 (2011)
68. Ledig S, Brucker S, Barresi G, Schomburg J, Rall K, Wieacker P: Frame shift mutation of LHX1 is associated with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Hum Reprod 27: 2872-2875 (2012)
69. Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI, Sovik O: A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β. Hum Mol Genet 8: 2001-2008 (1999)
70. Little M, Georgas K, Pennisi D, Wilkinson L: Kidney development: two tales of tubulogenesis. Curr Top Dev Biol 90: 193-229 (2010)
71. Magro G, Grasso S: Expression of cytokeratins, vimentin and basement membrane components in human fetal male Mullerian duct and perimullerian mesenchyme. Acta Histochem 97: 13-18 (1995)
72. Manivel JC, Sibley RK, Dehner LP: Complete and incomplete Drash syndrome: a clinicopathologic study of five cases of a dysontogeneticneoplastic complex. Hum Pathol 18: 80-89 (1987)
73. Masse J, Watrin T, Laurent A, Deschamps S, Guerrier D, Pellerin I: The developing female genital tract: from genetics to epigenetics. Int J Dev Biol 53: 411-424 (2009)
74. Mauch TJ, Yang G, Wright M, Smith D, Schoenwolf GC: Signals from trunk paraxial mesoderm induce pronephros formation in chick intermediate mesoderm. Dev Biol 220: 62-75 (2000)
75. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, et al: Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120: 2749-2771 (1994).
76. Mericskay M, Kitajewski J, Sassoon D: Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131: 2061-2072 (2004)
77. Miller C, Sassoon DA: Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125: 3201-3211 (1998)
78. Miller C, Pavlova A, Sassoon DA: Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech Dev 76: 91-99 (1998)
79. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, et al: Genetic analysis of the Mullerianinhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10: 2577-2587 (1996)
80. Mishina Y, Whitworth DJ, Racine C, Behringer RR: High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140: 2084-2088 (1999)
81. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S: Defects of urogenital development in mice lacking Emx2 . Development 124: 1653-1664 (1997)
82. Mortlock DP, Innis JW: Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 15: 179-180 (1997)
83. Nachtigal MW, Hirokawa Y, Enyeart-Van-Houten DL, Flanagan JN, Hammer GD, Ingraham HA: Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93: 445-454 (1998)
84. Nunnally AP, Parr BA: Analysis of Fz10 expression in mouse embryos. Dev Genes Evol 214: 144-148 (2004)
85. Obara-Ishihara T, Kuhlman J, Niswander L, Herzlinger D: The surface ectoderm is essential for nephric duct formation in intermediate mesoderm. Development 126: 1103-1108 (1999)
86. Oppelt P, Strissel PL, Kellermann A, Seeber S, Humeny A, et al: DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome. Hum Reprod 20: 149-157 (2005)
87. Oppelt P, Renner SP, Kellermann A, Brucker S, Hauser GA, et al: Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod 21: 792-797 (2006)
88. Orvis GD, Behringer RR: Cellular mechanisms of Mullerian duct formation in the mouse. Dev Biol 306: 493-504 (2007)
89. Orvis GD, Jamin SP, Kwan KM, Mishina Y, Kaartinen VM, et al: Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol Reprod 78: 994-1001 (2008)
90. Paranko J, Virtanen I: Epithelial and mesenchymal cell differentiation in the fetal rat genital ducts: changes in the expression of cytokeratin and vimentin type of intermediate filaments and desmosomal plaque proteins. Dev Biol 117: 135-145 (1986)
91. Parr BA, McMahon AP: Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a . Nature 395: 707-710 (1998)
92. Picon R: Action of the fetal testis on the development in vitro of the Mullerian ducts in the rat [in French]. Arch Anat Microsc Morphol Exp 58: 1-19 (1969)
93. Post LC, Margulies EH, Kuo A, Innis JW: Severe limb defects in hypodactyly mice result from the expression of a novel, mutant HOXA13 protein. Dev Biol 217: 290-300 (2000)
94. Reber M, Cereghini S: Variant hepatocyte nuclear factor 1 expression in the mouse genital tract. Mech Dev 100: 75-78 (2001)
95. Robert B, Lallemand Y: Anteroposterior patterning in the limb and digit specification: contribution of mouse genetics. Dev Dyn 235: 2337-2352 (2006)
96. Roberts LM, Visser JA, Ingraham HA: Involvement of a matrix metalloproteinase in MISinduced cell death during urogenital development. Development 129: 1487-1496 (2002)
97. Salehi P, Koh CJ, Pitukcheewanont P, Trinh L, Daniels M, Geffner M: Persistent Mullerian duct syndrome: 8 new cases in Southern California and a review of the literature. Pediatr Endocrinol Rev 10: 227-233 (2012)
98. Sandbacka M, Laivuori H, Freitas E, Halttunen M, Jokimaa V, et al: TBX6, LHX1 and copy number variations in the complex genetics of Mullerian aplasia. Orphanet J Rare Dis 8: 125 (2013)
99. Saxen L, Sariola H: Early organogenesis of the kidney. Pediatr Nephrol 1: 385-392 (1987)
100. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA: Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77: 651-661 (1994)
101. Tanwar PS, Zhang L, Tanaka Y, Taketo MM, Donahoe PK, Teixeira JM: Focal Mullerian duct retention in male mice with constitutively activated β-catenin expression in the Mullerian duct mesenchyme. Proc Natl Acad Sci USA 107: 16142-16147 (2010)
102. Taylor HS, Vanden Heuvel GB, Igarashi P: A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 57: 1338-1345 (1997)
103. Taylor HS, Igarashi P, Olive DL, Arici A: Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab 84: 1129-1135 (1999)
104. Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development. Development 121: 4057-4065 (1995)
105. Trelstad RL, Hayashi A, Hayashi K, Donahoe PK: The epithelial-mesenchymal interface of the male rate Mullerian duct: loss of basement membrane integrity and ductal regression. Dev Biol 92: 27-40 (1982)
106. Troy PJ, Daftary GS, Bagot CN, Taylor HS: Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10. Mol Cell Biol 23: 1-13 (2003)
107. Tsuji M, Shima H, Yonemura CY, Brody J, Donahoe PK, Cunha GR: Effect of human recombinant Mullerian inhibiting substance on isolated epithelial and mesenchymal cells during Mullerian duct regression in the rat. Endocrinology 131: 1481-1488 (1992)
108. Urioste M, Rodriguez JI, Barcia JM, Martin M, Escriba R, et al: Persistence of Mullerian derivatives, lymphangiectasis, hepatic failure, postaxial polydactyly, renal and craniofacial anomalies. Am J Med Genet 47: 494-503 (1993)
109. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, et al: PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 118: 1129-1137 (2005)
110. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405-409 (1999)
111. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, et al: Development of several organs that require inductive epithelialmesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691-2703 (1994)
112. Viebahn C, Lane EB, Ramaekers FC: The mesonephric (Wolffian) and paramesonephric (Mullerian) ducts of golden hamsters express different intermediate-filament proteins during development. Differentiation 34: 175-188 (1987)
113. Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dolle P: Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124: 4781-4791 (1997)
114. Warr N, Siggers P, Bogani D, Brixey R, Pastorelli L, et al: Sfrp1 and Sfrp2 are required for normal male sexual development in mice. Dev Biol 326: 273-284 (2009)
115. Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, et al: Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133: 2359-2369 (2006)
116. Zhao Y, Potter SS: Functional specificity of the Hoxa13 homeobox. Development 128: 3197-3207 (2001)
117. Zhu C, Zhao F, Zhang W, Wu H, Chen Y, et al: A familial WT1 mutation associated with incomplete Denys-Drash syndrome. Eur J Pediatr 172: 1357-1362 (2013).